Author: OurCrowd

[Replay Technologies in eWeek] Intel Shows Off the Reach of Its Technologies at CES

Intel is using CES 2016 this week to further prove that its silicon technologies aren’t just for PCs and servers anymore. Company CEO Brian Krzanich at the same event last year introduced Curie, the tiny development platform for wearable devices like smartwatches, bracelets and eyewear and sensors that help make up the Internet of things (IoT). At CES this year in Las Vegas, Krzanich announced a broad array of partnerships with such companies as ESPN, Red Bull, New Balance and Oakley that showcase myriad ways that Intel technologies—from Curie to the company’s RealSense 3D cameras—can be used in a wide array of smart and connected devices. Read more in...

Read More

OurCrowd’s portfolio company Replay Technologies featured in The Wall Street Journal

Leading business and finance website, The Wall Street Journal, featured OurCrowd’s portfolio company Replay Technologies. Free Dimensional Video (freeD), developed by Replay Technologies, provides sports fans with an immersive real-life viewing experience with a vision of true virtual reality sports viewing. Intel announced sports-oriented collaborations at the Las Vegas event with brands that included ESPN, New Balance, Red Bull Media House and the eyewear maker Oakley. […] The company said it is working with Replay Technologies to create instant three-dimensional models of sporting events like basketball games, allowing viewers to circle the action and view it from any angle. Replay Technologies raised $2,136,296 from OurCrowd investors in December 2015. Read more on the...

Read More

OurCrowd’s portfolio company ReWalk featured in Globes

OurCrowd portfolio company ReWalk was featured in Globes, the leading Israeli financial daily. ReWalk is the developer of the FDA-approved ReWalk exoskeleton device, providing paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits. The graph of Israeli company ReWalk Robotics Ltd.’s (Nasdaq:RWLK) share price is a good place for beginning the company’s story. ReWalk, which has developed an external skeleton enabling people with spinal cord injuries to walk, held its Nasdaq IPO in September 2014, two months after obtaining US Food and Drug Administration (FDA) approval for its product. The offering share price was $12. Over the ensuing 15 months, the share price declined slowly and consistently to a low point of less than $6. Two weeks ago came a total turnaround: the share price skyrocketed 90% in a single day, and has now reached almost $14.50, almost 140% above its low point. ReWalk raised $1,320,000 from OurCrowd investors in June 2013. Read more on...

Read More

Prevent Diabetes: A new way for 86M prediabetics to go off course

While diabetes is undoubtedly a big problem, with 29.1 million diabetics in the US, approximately 60 million in Europe, and 371 million across the globe, there are considerably more people who qualify as “pre-diabetic”. In fact, 86 million Americans are estimated to be pre-diabetic. The statistics are overwhelming: Half of all healthy 45-year-olds will develop prediabetes, a condition of elevated blood sugar that can lead to full-blown insulin-dependent Type II diabetes, according to a recent comprehensive study in The Netherlands. At the same time, there is also room for hope: Making lifestyle changes while prediabetic can reduce one’s risk of developing actual diabetes by 58%, according to a 2002 U.S. government-funded study. But that is much easier said than done. In order to significantly reduce one’s risk, individuals need to exercise for two and a half hours each week, and eat less fat and fewer calories, ideally reducing their body weight by 7%, according to the 2002 study. And those participating in the study that achieved this outcome had a team of counselors offering instruction and motivation, as well...

Read More

WEBINAR: How experienced investors evaluate – and invest through – online equity platforms

In an industry barely a few years old and growing quickly, angel investors are faced with multiple choices when deciding if they should try an accredited investor equity platform for startup investments. It can be exciting and daunting as the platforms themselves differ greatly in their business model, deal types, and possible outcomes. Join Rany Raviv, VP Business Development and M&A Iberdrola Renewables, Sarit Rozycki, President at SLR Associates in NYC, Shai Magzimof, CEO & Co-Founder of NextPeer, and Jonathan Medved, CEO of OurCrowd, for a 60-minute webinar with Angel Capital Association exploring the various online equity platforms for startup investing. Investor Experiences with Online Equity Platforms Wednesday, January 13th, 2016 (7:00 PM Israel / 12:00 PM NYC / 3:00 PM San Francisco) In this webinar, you will: Learn from two experienced angel investors who’ve each invested through several different platforms. Learn how they evaluate platforms, including differences in experience, term sheets and, of course, deal flow. >> Reserve your seat on the webinar Moderator: Bill Carleton, Attorney with McNaul Ebel Nawrot & Helgren. Bill is a key member of the ACA public policy...

Read More